Stockreport

Does New Melanoma Data Redefine the Bull Case for Castle Biosciences' DecisionDx Platform (CSTL)? [Yahoo! Finance]

Castle Biosciences, Inc. - Common stock  (CSTL) 
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm Check Earnings Report
PDF In November 2025, Castle Biosciences announced new clinical data supporting its DecisionDx-Melanoma test for improving sentinel lymph node biopsy decision making and rec [Read more]